New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareProstamax vs Matrixyl

Prostamax vs Matrixyl

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Prostamax
Skin & Cosmetic
Matrixyl
Summary
Prostamax is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) developed by Professor Vladimir Khavinson, tissue-specific for the prostate gland. It supports prostate epithelial cell function, promotes normalization of prostate tissue, and is studied for its potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate anti-aging. It is one of the more widely used Khavinson bioregulators among men over 40.
Matrixyl is the most widely used collagen-stimulating cosmetic peptide. As a matrikine — a fragment of type I procollagen — it signals skin cells to synthesize new collagen, elastin, and fibronectin, reducing wrinkle depth and improving skin firmness and elasticity.
Half-Life
Short (minutes); sustained gene-regulatory effects
N/A — topical; sustained signaling effects on fibroblasts persist beyond single application
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
3–8% concentration
Frequency
Daily for 10–30 days
Once or twice daily
Key Benefits
  • Supports normalization of prostate tissue architecture
  • May reduce prostate enlargement associated with BPH
  • Anti-inflammatory effects on prostatic tissue
  • Reduces prostate cell apoptosis from oxidative stress
  • Potential support in chronic prostatitis
  • Anti-aging effects on prostate glandular tissue
  • Complementary to conventional BPH therapies
  • Stimulates collagen I, III, and IV synthesis
  • Increases fibronectin and glycosaminoglycan production
  • Reduces wrinkle depth and length by 27–68% (studies)
  • Improves skin firmness and elasticity
  • Reduces dark circles and undereye bags
  • Synergistic with retinol, vitamin C, and growth factors
  • Suitable for all skin types including sensitive
  • Well-studied with published clinical data
Side Effects
  • Generally well tolerated in available research
  • Mild injection site reactions
  • No significant adverse urological events reported at standard doses
  • Exceptional safety profile
  • Non-irritating, suitable for sensitive skin
  • No known adverse effects at cosmetic concentrations
Stacks With